Parallel Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74K | Buy |
1,872
+1,127
| +151% | +$44.5K | ﹤0.01% | 1507 |
|
|
2025
Q1 | $22.5K | Sell |
745
-214
| -22% | -$6.46K | ﹤0.01% | 2066 |
|
|
2024
Q4 | $33.5K | Sell |
959
-69
| -7% | -$2.41K | ﹤0.01% | 1867 |
|
|
2024
Q3 | $41.2K | Buy |
1,028
+396
| +63% | +$15.9K | ﹤0.01% | 1723 |
|
|
2024
Q2 | $30.1K | Buy |
632
+60
| +10% | +$2.86K | ﹤0.01% | 1762 |
|
|
2024
Q1 | $24.8K | Buy |
572
+7
| +1% | +$303 | ﹤0.01% | 1864 |
|
|
2023
Q4 | $28.6K | Sell |
565
-106
| -16% | -$5.36K | ﹤0.01% | 1726 |
|
|
2023
Q3 | $30.4K | Sell |
671
-40
| -6% | -$1.81K | ﹤0.01% | 1634 |
|
|
2023
Q2 | $29.2K | Buy |
711
+40
| +6% | +$1.64K | ﹤0.01% | 1671 |
|
|
2023
Q1 | $24K | Hold |
671
| – | – | ﹤0.01% | 1744 |
|
|
2022
Q4 | $25.3K | Sell |
671
-51
| -7% | -$1.93K | ﹤0.01% | 1600 |
|
|
2022
Q3 | $32K | Sell |
722
-2
| -0.3% | -$89 | ﹤0.01% | 1451 |
|
|
2022
Q2 | $27K | Buy |
724
+8
| +1% | +$298 | ﹤0.01% | 1513 |
|
|
2022
Q1 | $26K | Buy |
716
+95
| +15% | +$3.45K | ﹤0.01% | 1587 |
|
|
2021
Q4 | $19K | Sell |
621
-102
| -14% | -$3.12K | ﹤0.01% | 1807 |
|
|
2021
Q3 | $24K | Buy |
723
+295
| +69% | +$9.79K | ﹤0.01% | 1612 |
|
|
2021
Q2 | $17K | Sell |
428
-2,534
| -86% | -$101K | ﹤0.01% | 1743 |
|
|
2021
Q1 | $133K | Buy |
2,962
+485
| +20% | +$21.8K | 0.01% | 768 |
|
|
2020
Q4 | $140K | Buy |
2,477
+1,567
| +172% | +$88.6K | 0.01% | 691 |
|
|
2020
Q3 | $43K | Sell |
910
-2,213
| -71% | -$105K | ﹤0.01% | 1101 |
|
|
2020
Q2 | $184K | Buy |
3,123
+2,236
| +252% | +$132K | 0.01% | 565 |
|
|
2020
Q1 | $41K | Sell |
887
-1,933
| -69% | -$89.3K | ﹤0.01% | 1012 |
|
|
2019
Q4 | $170K | Buy |
2,820
+2,000
| +244% | +$121K | 0.01% | 564 |
|
|
2019
Q3 | $49K | Hold |
820
| – | – | ﹤0.01% | 989 |
|
|
2019
Q2 | $53K | Sell |
820
-700
| -46% | -$45.2K | 0.01% | 864 |
|
|
2019
Q1 | $123K | Sell |
1,520
-550
| -27% | -$44.5K | 0.01% | 537 |
|
|
2018
Q4 | $111K | Sell |
2,070
-953
| -32% | -$51.1K | 0.02% | 496 |
|
|
2018
Q3 | $156K | Buy |
3,023
+2,000
| +196% | +$103K | 0.02% | 459 |
|
|
2018
Q2 | $42K | Sell |
1,023
-900
| -47% | -$37K | 0.01% | 787 |
|
|
2018
Q1 | $85K | Sell |
1,923
-2,300
| -54% | -$102K | 0.01% | 546 |
|
|
2017
Q4 | $212K | Buy |
4,223
+900
| +27% | +$45.2K | 0.03% | 307 |
|
|
2017
Q3 | $182K | Buy |
3,323
+1,250
| +60% | +$68.5K | 0.03% | 334 |
|
|
2017
Q2 | $109K | Buy |
2,073
+800
| +63% | +$42.1K | 0.02% | 449 |
|
|
2017
Q1 | $61K | Buy |
1,273
+500
| +65% | +$24K | 0.01% | 595 |
|
|
2016
Q4 | $37K | Buy |
+773
| New | +$37K | 0.01% | 670 |
|